Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. securities between January 3, 2024 and December 2, ...

the Phase 1/2 ACTION-Galactosemia study in adult patients with Galactosemia, and preclinical data as well as positive interim trial results from the Phase III INSPIRE trial. Then, on December 2 ...

May also be called: Galactose-1-Phosphate Uridyltransferase Deficiency; Galactokinase Deficiency; Galactose-6-Phosphatase Emirase Deficiency; GALT Deficiency; Galactose Epimerase Deficiency; Classic ...

ed.ac.uk Myocardial injury is common in patients without acute coronary syndrome, and international guidelines recommend patients with myocardial infarction are classified by aetiology. The universal ...

The amount of time spent in EMT class dedicated to the knowledge and skills needed to patient assessment clearly indicates the importance placed on the EMT having the ability to competently ...

Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter 1 from the US Food and Drug Administration ...

A South Australian GP has been suspended over an inappropriate relationship with a patient in her 80s. Hemant Kumar Vanmali had an intimate relationship with the woman whom he had treated for more ...

Results 1117 participants across six sites were included in the analysis. Compared with usual care, the combined use of both the patient decision aid and the encounter decision aid improved the ...

The decision not to approve the drug was met with consternation by the Galactosemia Foundation, which represents patients with the disorder, and which called the outcome "devastating." There are ...

Earlier this month, a newer patient came in to see me for a check-up and discussion about her extremely high cholesterol level. In her late 50s with a family history of early-age heart attack ...